Delivery Order SPE2DB25D3306-SPE2DB25FUBAX

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,527.17, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,361.24, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, and has a completion date of December 19, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $4,664.55, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation mentioned. AmerisourceBergen Drug Corp has a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,014.30 and has a completion date of February 6, 2025. It is for the supply of 4567175524 BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, to support military healthcare programs. The contract has no set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,137.12 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of May 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,278.81 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a respiratory medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,336.61 delivery order contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product used for respiratory conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an award value of $2,647.56 and is a Firm Fixed Price Delivery Order for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,417.24 for the product "BUDESONIDE-FORMOTEROL 160-4.5 10.2GM." The award has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,310.40 firm fixed-price delivery order contract is for the supply of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUBAX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $4,126.52, with a firm fixed price and a ceiling value of $4,126.52. The contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/9/25, 9:42 AM